Cost-effectiveness analyses of targeted therapy and immunotherapy for advanced non-small cell lung cancer in the United States: a systematic review

Anthony F. Yu(Memorial Sloan Kettering Cancer Center), Chanhyun Park(Northeastern University), Eva Huang(Northeastern University), Momoka Abe(Northeastern University), Sun‐Kyeong Park(Sungkyunkwan University), Kang An(Nanjing University of Chinese Medicine)
Expert Review of Pharmacoeconomics & Outcomes Research
February 9, 2021
Cited by 11


Related Papers